Low-dose radiotherapy: clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving Low-dose radiotherapy

• LDRT Combined With Immunochemotherapy for Colorectal Cancer With Liver Metastasis
  NCT06848465 · Phase: Phase 1 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 2 locations
• LDRT Combined With Pucotenlimab and Standard Therapy for Advanced Pancreatic Cancer: A Single-Arm Study
  NCT07312422 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Low-Dose Radiotherapy to Sensitize Pucotenlimab Plus CAPEOX for pMMR Locally Advanced Rectal Cancer
  NCT07448142 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Extensive-Stage Small Cell Lung Cancer (SCLC)
  NCT06610734 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Radio- KO Radiotherapy for Knee Osteoarthritis Clinical Trial
  NCT06887829 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 100 Years · Sex: All (male and female) · 1 location
• Safety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLC
  NCT06217757 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Low-dose radiotherapy?

6 recruiting trials across 13 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.